Abstract

CESPEDES, María Eugenia. D2 receptor polymorphisms. Rev. argent. endocrinol. metab. [online]. 2017, vol.54, n.1, pp.29-36. ISSN 1851-3034.

Prolactinomas are well differentiated tumours that originate in the pituitary lactotrope cells, a cell line that physiologically secretes prolactin (PRL). At pituitary level, dopamine is involved in the regulation of PRL secretion by lactotropes, and this inhibitory effect is mediated by activation of prolactin type 2 receptor (DRD2). Of the several DRD2 polymorphisms, the first and most studied is TaqI A1. It has been demonstrated that this allele is associated with a reduced dopaminergic brain activity, and a reduction in its binding capacity of approximately 30% also being observed. This allele was associated with a lower density of DRD2 in the striatum, especially in the putamen and ventral caudate. The amount of DRD2 in A1 allele carriers was 30 - 40% lower than in non-carriers (this is, TaqI A2 Homozygotes). There is evidence in the literature, that supports the possible involvement of DRD2 polymorphisms in the regulation of hormonal secretion.

Keywords : Prolactinoma; Dopamine D2 receptor; DRD2 isoforms; DRD2 polymorphisms.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )